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Introduction

5
The 'Magnetic Resonance imaging to enhance the diagnosis of fetal developmental brain 6 abnormalities in utero' (MERIDIAN) study is a multi-centre, prospective cohort study 7 designed to evaluate the diagnostic and clinical impact of in utero MR (iuMR) imaging of 8 fetal brain abnormalities 1 . The synoptic overview of the MERIDIAN results has been 9 reported elsewhere 2 and describes improvements in diagnostic accuracy (at least 22%) when 10 iuMR is included in the diagnostic pathway of fetuses with suspected brain abnormalities 11 recognised on ultrasonography (USS). Diagnostic changes were accompanied by major 12 changes in counselling of pregnant women and changes in management.
13
A further facet of diagnostic impact, diagnostic confidence, was analysed on a descriptive 14 level in the earlier paper and showed encouraging results, with an overall increase in 15 diagnoses made with high confidence by 13% on iuMR compared with USS 2 . There was a 16 3.5-fold reduction of incorrect diagnoses made with high confidence on iuMR compared with 17 USS and a 2.5-fold reduction of correct diagnoses made with low confidence on iuMR.
18
In this paper we perform additional analyses on the MERIDIAN cohort to assess whether 19 improvement in diagnostic accuracy was matched by an increase in diagnostic confidence.
20
The cohort was analysed on an individual case basis by three assessments; prior to entering the study.
36
The primary results of MERIDIAN have been presented elsewhere 2 . In this paper we provide 37 a detailed assessment of the changes in diagnostic confidence on that same cohort. was accompanied by a confidence rating using the same Likert scale as the USS assessment.
80
The 'diagnosis excluded' option was attributed a 90% certainty.
82
Data Handling and analysis
83
The assessment of diagnostic confidence used in this report is based on the 'dominant 84 diagnosis'. In cases where there was only one anatomical/pathological diagnosis this was 85 straightforward but in cases with more than one diagnosis the independent panels defined the tabulated diagnostic results for each fetus and were blinded to whether it was an USS or an 97 iuMR report. They were asked whether each report agreed with the ORD completely and,
98
where USS and iuMR disagreed, which one indicated the more severe pathology. The results
99
were subsequently unblinded by staff at Sheffield CTRU. with 90% confidence the Omary corrected score is (C2-[100-C1])% = 90-10% = 80% = +4).
126
In any cases where the criteria for the Omary correction are not met then the conventional 127 uncorrected score is unchanged. The rationale for applying the Omary correction and its
128
implications are described in the discussion. with high confidence the 'score-based weighted average' result will depend on the ORD. If
146
ACC was confirmed, the route label would be A1 with route score +4, whereas if VM was 147 the ORD the route label E5 gives a route score of -3. This is based on the presumption that the new test (iuMR) is correct.
149
For all three types of analyses the frequency of each integer score was plotted as a bar chart uncorrected C2-C1% method in 570 fetuses is shown in Figure 2a . A difference in confidence 160 levels of the dominant diagnosis of any degree was present in 42% of cases, among which the 161 majority were made with greater confidence following iuMR (32%) rather than USS (10%).
162
The mean difference in confidence on the ordinal -4 to +4 scale was +0·44 in favor of iuMR
163
(95% CI 0.35 to 0.54, p<0·0001; see Table 2 ). any degree was present in 52% of all cases, 47% were more confident on iuMR and 5% more 170 confident on USS. The mean difference in confidence was +1·10 in favor of iuMR (95%CI 171 0.98 to 1.25, p<0·0001; see Table 2 ). The route labels for the 570 cases included in this study are presented in Table 3 . A
175
histogram of the frequency versus score data analyzed by the 'score-based weighted average' 176 method is shown in Figure 2c . A difference in confidence levels of the dominant diagnosis of 177 any degree was present in 38% of all cases and the score was positive in 31% (indicating that 178 an appropriate increase in diagnostic confidence for iuMR) and negative in 7%). The mean 179 difference in confidence was +0·75 (95% CI 0.63 to 0.87, p<0·0001; see Table 2 ). together with the encouraging findings of previous systematic reviews and meta-analyses 7-10 ,
188
suggests that iuMR increases the accuracy of fetal brain diagnoses compared to USS alone.
189
Whilst some of these systematic reviews and meta-analyses have their limitations, such as a
190
lack of outcome reference data and reporting of the time difference between the examinations 191 the MERIDIAN study was able to overcome these as it was a prospective study designed to 192 address these limitations. Despite the difference in methods between the reviews and our 193 study, all conclude this similar finding; therefore adding weight to the evidence base.
194
The relevance of diagnostic accuracy in assessing an imaging technology is self-evident but route labels -route score ranging from -1 to -3).
252
In contrast, iuMR studies will receive positive scores in situations such as; 
